We are a human-sized, international, and independent pharmaceutical group, governed by a Foundation. Our unique model is a source of pride, but above all, it allows us to fully serve our mission: “Committed to therapeutic progress for the benefit of patients.”
Today, a global leader in cardiology, we have chosen to become a focused and innovative player in oncology by 2030, targeting hard-to-treat cancers and dedicating more than 70% of our R&D budget to this area. We are committed to equal opportunities and the development of talent in all its diversity. We value both experience and the willingness to engage daily to contribute to therapeutic progress for the benefit of patients. If you see yourself reflected in this offer and these few lines, seize the opportunity to meet us. We pursue this challenge alongside the development of our generics business, ensuring access to quality care for all, at a lower cost.
Who are we? More than 20,000 passionate individuals from over 50 nationalities, driven by an entrepreneurial spirit. Every day, we move forward with and for patients, with and for our teams, guided by the desire to care, to take risks, to grow, and to commit ourselves to be useful to those in need.
Come experience and help bring our commitment to life: #MovedByYou
Join us at a pivotal moment as we continue to strengthen and harmonize our global Field Medical capabilities. As Global MSL Excellence Lead, you will play a key role in shaping the future of the global MSL community at Servier by driving excellence, capability building, and impactful scientific engagement worldwide.
Why Join Us? This is a unique opportunity to shape the future of Servier’s MSL excellence at a global level. Join us and be part of this exciting momentum as we accelerate our growth, bring innovative therapies to patients, and build the future of healthcare together.
We are committed to equal opportunities and the development of talent in all its diversity. We value both experience and the willingness to engage daily to contribute to therapeutic progress for the benefit of patients. If you see yourself reflected in this offer and these few lines, seize the opportunity to meet us.

Servier is an independent international pharmaceutical group governed by a foundation. With its unique governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine life cycle.
As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. Through precision medicine, the Group intends to offer targeted therapeutic solutions for a limited number of rare diseases and invests nearly 20% of its brand-name sales in R&D.
Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion.
--
To report a suspected adverse event with a Servier drug, please visit servier.com